Atopic dermatitis care is evolving with flexible biologic dosing, expanded pediatric options, and novel oral, topical, and systemic therapies.
News|Articles|January 1, 2024
Dermatology Times' 2024 Health Awareness Calendar of Dates
Author(s)Emma Andrus, Associate Editor
Click here to view Dermatology Times' comprehensive list of health awareness days, months, weeks, and initiatives for 2024.
Advertisement
With a new year just beginning, Dermatology Times has put together a comprehensive list of dermatology-related health awareness dates for 2024.
Throughout the year, we will provide the latest updates, interviews, studies, and resources to commemorate these awareness initiatives all in the name of improving patient care.
Spot any dermatologic awareness initiatives we may missed in our roundup? Share with us by emailing our team at
January
February
- Month: National Cancer Prevention Month
- February 29: Rare Disease Day
March
April
- Month: Rosacea Awareness Month
May
- Month: Psoriatic Arthritis Action Month
- Month: Skin Cancer Awareness/Prevention Month
- May 6: Melanoma Monday
- May 24: Actinic Keratosis (AK) Global Day
- May 31: Necrotizing Fasciitis Awareness Day
June
- Month: Acne Awareness Month
- Month: Scleroderma Awareness Month
- Month: Vitiligo Awareness Month
- June 2-8: Hidradenitis Suppurativa (HS) Awareness Week
- June 13: International Albinism Awareness Day
- June 25: World Vitiligo Day
- June 28: National Climate-Smart Skin Awareness Day
- June 29: World Scleroderma Day
July
- Month: UV Safety Month
- Month: Hyperpigmentation/Melasma Awareness Month
August
- Month: Hair Loss Awareness Month
- Month: Psoriasis Awareness/Action Month
September
- Month: Alopecia Awareness Month
- Month: Skin Care Awareness Month
- September 14: World Atopic Eczema Day
- September 15-22: National Eczema Week
- September 28: Psoriatic Arthritis Awareness Day
October
- Month: Eczema Awareness Month
- October 1-7: Body-Focused Repetitive Behaviors (BFRB) Awareness Week
- October 6-12: National Physician Assistant (PA) Week
- October 29: World Psoriasis Day
November
- Month: Hyperhidrosis Awareness Month
- Month: National Healthy Skin Month
- November 10-16: National Nurse Practitioner (NP) Week
- November 20: BOTOX Cosmetic (OnabotulinumtoxinA) Day
December
Advertisement
Related to this article
Updated SKYRIZI labeling allows clinicians to use clinical judgment when determining the need for TB evaluation before treatment.
Experts outline how to recognize undertreated psoriasis, assess incomplete response, and make individualized decisions when escalating therapy.
ATI-052 improved disease severity and itch in a phase 1b trial of patients with severe atopic dermatitis, with no grade 3 or 4 adverse events.
LRM will evaluate injectable rhPDGF-BB as a regenerative approach to infraorbital hollowing in a randomized phase 2b trial.
ORKA-001 achieved PASI 100 in 61% of high-dose patients at week 16 in the phase 2b EVERLAST-B trial of moderate-to-severe psoriasis.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Stratman discusses individualized eczema care, expanding treatment options, and the potential of precision medicine to guide therapy.
Advertisement
Advertisement
Trending on Dermatology Times
1
How Approvals, Setbacks, and a Crowded Pipeline Are Reshaping the AD Treatment Landscape
2
ORKA-001 Achieves 61% Complete Skin Clearance in Psoriasis
3
ATI-052 Shows Rapid Improvements in Atopic Dermatitis
4
FDA Revises TB Evaluation Guidance for SKYRIZI
5